These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24503941)

  • 21. Current approach to hemochromatosis.
    Brissot P; Troadec MB; Bardou-Jacquet E; Le Lan C; Jouanolle AM; Deugnier Y; Loréal O
    Blood Rev; 2008 Jul; 22(4):195-210. PubMed ID: 18430498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of hemochromatosis.
    Powell LW; George DK; McDonnell SM; Kowdley KV
    Ann Intern Med; 1998 Dec; 129(11):925-31. PubMed ID: 9867744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient elevation of serum ferritin in a Sri Lankan with homozygosity for H63D mutation in the HFE gene: a case report.
    Wickramasinghe W; Karunathilaka C; Jayasinghe S; Gooneratne L
    J Med Case Rep; 2020 Jul; 14(1):93. PubMed ID: 32641120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [28-year old patient with successfully treated dilatative cardiomyopathy].
    Burri E; Decker M; Eriksson U; Buser P; Hunziker L
    Internist (Berl); 2008 Mar; 49(3):349-52. PubMed ID: 18210019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress.
    Das SK; Patel VB; Basu R; Wang W; DesAulniers J; Kassiri Z; Oudit GY
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28115312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study.
    Cançado R; Melo MR; de Moraes Bastos R; Santos PC; Guerra-Shinohara EM; Chiattone C; Ballas SK
    Eur J Haematol; 2015 Dec; 95(6):545-50. PubMed ID: 25684349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
    Hicken BL; Tucker DC; Barton JC
    Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis of 5 patients with possible primary hemochromatosis].
    Jacobs EM; de Vries RA; Elving LD; Stalenhoef AF; Swinkels DW
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):666-70. PubMed ID: 12712652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*.
    Kolnagou A; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2006; 30(2):219-27. PubMed ID: 16798647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary hemochromatosis.
    Walker EM; Wolfe MD; Norton ML; Walker SM; Jones MM
    Ann Clin Lab Sci; 1998; 28(5):300-12. PubMed ID: 9784832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A young diabetic with small-nodule liver cirrhosis, high transferrin saturation and negative HFE test].
    Eisold M; Gehrke S; Stremmel W; Gugler R
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1494-6. PubMed ID: 15942838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and management of hereditary hemochromatosis.
    Salgia RJ; Brown K
    Clin Liver Dis; 2015 Feb; 19(1):187-98. PubMed ID: 25454304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review article: the iron overload syndromes.
    Siddique A; Kowdley KV
    Aliment Pharmacol Ther; 2012 Apr; 35(8):876-93. PubMed ID: 22385471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing the diagnosis and the treatment of iron overload diseases.
    Brissot P
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):359-70. PubMed ID: 26561304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of liver magnetic resonance imaging in hyperferritinaemia and the diagnosis of iron overload.
    Ruefer A; Bapst C; Benz R; Bremerich J; Cantoni N; Infanti L; Samii K; Schmid M; Vallée JP
    Swiss Med Wkly; 2017; 147():w14550. PubMed ID: 29120023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH).
    Fabio G; Minonzio F; Delbini P; Bianchi A; Cappellini MD
    Blood; 2007 Jan; 109(1):362-4. PubMed ID: 16960153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary hemochromatosis: laboratory evaluation.
    Moyer TP; Highsmith WE; Smyrk TC; Gross JB
    Clin Chim Acta; 2011 Aug; 412(17-18):1485-92. PubMed ID: 21510925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of a hemochromatosis next-generation sequencing gene panel.
    Lanktree MB; Sadikovic B; Waye JS; Levstik A; Lanktree BB; Yudin J; Crowther MA; Pare G; Adams PC
    Eur J Haematol; 2017 Mar; 98(3):228-234. PubMed ID: 27753142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI.
    Golfeyz S; Lewis S; Weisberg IS
    Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):767-778. PubMed ID: 29966105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac Magnetic Resonance at 3.0 T in Patients With C282Y Homozygous Hereditary Hemochromatosis: Superiority of Radial and Circumferential Strain Over Cardiac T2* Measurements at Baseline and at Post Venesection Follow-up.
    Byrne D; Walsh JP; Murphy RT; McMorrow J; Fagan AJ; Kecler Poetrzyk A; Durand ME; Norris S; McKiernan S; King G; Meaney JF; Daly C
    J Thorac Imaging; 2022 Sep; 37(5):300-306. PubMed ID: 35426858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.